Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,091,511
+$410,946 QoQ
Shares Held
47,610
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.64%
of 13F equity value
Holder Rank
#997
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLY LAWRENCE W & ASSOCIATES INC/CA holds $15,835,572 across 7 Drug Manufacturers - General names. JNJ ranks #1 (76.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
47,610 | $12,091,511 | |
| 2 | ABBV |
AbbVie Inc.
|
7,791 | $1,960,527 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
6,044 | $763,598 | |
| 4 | AMGN |
Amgen Inc
|
1,398 | $506,243 | |
| 5 | LLY |
ELI LILLY & Co
|
227 | $272,270 | |
| 6 | PFE |
Pfizer Inc
|
9,130 | $219,850 | |
| 7 | NVO |
Novo Nordisk A S
|
450 | $21,573 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,091,511 | 47,610 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,680,565 | 47,785 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,566,038 | 51,056 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,466,803 | 51,056 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,598,144 | 56,289 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,775,604 | 58,946 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,550,078 | 59,121 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,104,926 | 62,353 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,147,277 | 62,584 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,410,008 | 65,807 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,746,877 | 68,565 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,993,613 | 70,585 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,721,960 | 70,819 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,171,935 | 72,077 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,830,619 | 72,633 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,079,254 | 80,064 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $14,326,654 | 80,709 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,409,330 | 81,303 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,896,528 | 81,233 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,253,658 | 82,066 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,508,020 | 81,996 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,401,262 | 81,541 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,447,056 | 53,673 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $12,401,852 | 83,301 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $17,604,625 | 125,184 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $16,470,059 | 125,601 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||